Both in Biotechnology
BioCryst Pharmaceuticals vs Hemab Therapeutics Holdings
Over the past year BCRX returned +5.5% and COAG returned +9.4%; their daily moves had a correlation of 0.39.
BCRX +5.5% COAG +9.4%Growth of $1, one year, split-adjusted
| Metric | BCRX | COAG |
|---|---|---|
| Price | $8.57 | $43.10 |
| Market cap | $2.19B | $2.01B |
| Today | +3.94% | +4.66% |
| 1 month | +5.8% | +40.9% |
| 6 months | −5.1% | — |
| Year to date | +9.9% | — |
| 1 year | +17.1% | — |
| Revenue growth (YoY) | +33.6% | — |
| Gross margin | 98.2% | — |
| Net margin | 35.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.3× | — |
| Net cash | -$471.6M | $457.5M |
| Dividend yield | — | — |
| Volatility (60d) | 44.9% | — |
| Short % of float | 10.9% | 20.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).